Viewing Study NCT05113732


Ignite Creation Date: 2025-12-24 @ 9:36 PM
Ignite Modification Date: 2025-12-29 @ 8:10 AM
Study NCT ID: NCT05113732
Status: UNKNOWN
Last Update Posted: 2021-11-09
First Post: 2021-10-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Association of Cognition With Functional Mobility in People With Alzheimer's Disease
Sponsor: Istanbul University - Cerrahpasa
Organization:

Study Overview

Official Title: Association of Cognition With Functional Mobility in People With Alzheimer's Disease
Status: UNKNOWN
Status Verified Date: 2021-10
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study aimed to investigate relationship between cognitive function and functional mobility in Alzheimer's disease.
Detailed Description: Our hypothesis is that the decrease in cognitive function in individuals with Alzheimer's disease is associated with the level of functional mobility. Sociodemographic information of participants will be recorded. Cognition will assessed with Montreal Cognitive Assessment (MoCA), global score and MoCA's visuospatial executive functions, naming, attention, language, abstract thinking, delayed recall, orientation sub-scores will recorded. Functional mobility will assessed Timed Up and Go Test and 5 Times Sit\&Stand Test.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: